Opportunity
Mental health needs were disproportionately high among health care workers (HCWs) before the COVID-19 pandemic. However, the rapid spread of the disease forced providers to grapple with additional stressors, including longer shifts, shortages of personal protective equipment, increased mortality and morbidity, and isolation.
As the pandemic continues, more and more HCWs are experiencing psychiatric symptoms, including post-traumatic stress, acute anxiety, substance use, depression, and suicide.
Intervention
COBALT is a HIPAA-compliant web-based platform that offers HCWs immediate access to mental health support. It was developed by clinicians at Penn Medicine with support from the Penn Medicine Center for Health Care Innovation and launched during the spring of 2020.
We are conducting a randomized control trial to assess the effectiveness of the platform to support the mental health of HCWs during the response and recovery phases of the COVID-19 pandemic.
Impact
We are currently recruiting Penn Medicine HCWs for this study. If you are interested in joining this paid research study, please complete this short survey to determine your eligibility.
